Selwyn Ho, MBBS, BSc
Executive in Residence
Dr. Selwyn Ho currently serves as Chief Business Officer at Connect Biopharma, a global clinical-stage company focused on improving the lives of patients living with T cell-driven chronic inflammatory diseases. He is also Founder & Managing Director of Artemis Catalyst, a management consultancy that provides strategic advisory services to biotech, biopharma, and private markets firms. Prior to his own consulting firm, he held senior positions in biotech and biopharmaceutical corporations, leading Global, Regional, and Country teams in the product development, product strategy, and commercialization of multiple medicines. Most recently, he served at Dermira as Vice President, Head of Global Market Access, and Vice President, Head of Global Strategic Marketing. Prior to Dermira, he held various senior roles at UCB S.A., including Vice President, Global Marketing (Immunology), and Vice President, Head of International Markets (Immunology). Prior to joining UCB, Dr. Ho had roles of increasing responsibility at Allergan, Novartis, and AstraZeneca. He received his medical degree (MB BS) and Bachelor of Science (BSc) in Pharmacology from Imperial College, University of London.